Patent · US Active

Method for manufacturing fungal pharmaceutical composition

US10131716B2 · kind B2 · utility

2Cited by
2References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 20, 2016
Grant dateNov 20, 2018
Priority date
Expiry dateDec 20, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2236/33
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a method for manufacturing fungal pharmaceutical composition, used for extracting a glycosaminoglycan fiber from a fungal cell wall. Differing from the glycosaminoglycan fiber produced by using a fabrication method proposed by Taiwan patent No. 442496 showing many drawbacks including low extraction percentage, coarse fiber, and having light-yellow color, the glycosaminoglycan fiber manufactured by using this novel method reveals the advantages of high extraction percentage, fine fibers, and showing white color. So that, the novel glycosaminoglycan fiber produced by using the present invention's method is suitable for being processed to an excipient. Moreover, because a variety of experimental results have proved that the glycosaminoglycan fiber produced by using the present invention's method possesses good adsorption ability of tissue fluid and moisture retention ability, this novel glycosaminoglycan fiber is also suitable for being processed to a skin dressing, an artificial skin, or a hydrate mask.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.